Cargando…
Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1
VSA-1 is a semisynthetic saponin adjuvant prepared from naturally occurring Momordica saponin and capable of stimulating antigen-specific humoral and cellular immune responses. Its immunostimulating activity in enhancing the immune responses induced by the clinical glycoconjugate pneumococcal vaccin...
Autores principales: | Kim, Hyunjung, Yu, Jigui, Bai, Di, Nahm, Moon H., Wang, Pengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790987/ https://www.ncbi.nlm.nih.gov/pubmed/36578488 http://dx.doi.org/10.3389/fimmu.2022.1079047 |
Ejemplares similares
-
Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination
por: Bhatnagar, Noopur, et al.
Publicado: (2022) -
Ficolin-2 Lectin Complement Pathway Mediates Capsule-Specific Innate Immunity Against Invasive Pneumococcal Disease
por: Nahm, Moon H., et al.
Publicado: (2022) -
Potentials of saponins-based adjuvants for nasal vaccines
por: Chen, Kai, et al.
Publicado: (2023) -
Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy
por: Ansaldi, Filippo, et al.
Publicado: (2020) -
2710. Novel Analytical Models for Pneumococcal Multiplex Opsonophagocytosis Assay Results from a Healthy Older Adult Population Vaccinated with PCV13
por: LaFon, David, et al.
Publicado: (2019)